Stirling Square Capital Partners has sold its portfolio company Vision Ophthalmology Group GmbH (VOG) to listed Swedish AddLife AB. VOG has a turnover of approximately EUR 70 million and has 190 employees. The initial purchase price is EUR 165 million, of which 50 percent is being paid in cash and 50 percent via existing repurchased and newly issued class B shares. An additional consideration of a maximum of EUR 18 million may become payable. VOG is a leading independent European provider of high quality solutions for ophthalmology and eye surgery with operations in Switzerland, Germany, the UK and Poland. AddLife is an independent provider of products, services and advice in the Life Science industry, focused on the Nordic region and rest of Europe. As part of the exit, VOG's financing provided by Ares was fully redeemed.
Hengeler Mueller advised Stirling Square Capital Partners together with Swedish law firm Vinge (lead partner Magnus Pauli) on the transaction. The team was led by partner Daniel Wiegand (M&A, Munich) and included partners Nikolaus Vieten and Daniela Böning (both Financing, Frankfurt) as well as associates Christian Lutz, Isabella Stocks (both M&A, Munich) and Fabian Berdin (Financing, Berlin).